Navigation Links
iBio, Inc. Prices $4.2 Million Public Offering
Date:4/23/2013

NEWARK, Del., April 23, 2013 /PRNewswire/ -- iBio, Inc. (NYSE MKT: IBIO) announced today the pricing of an underwritten public offering of 8,925,000 units at $0.48 per unit for gross proceeds of approximately $4,280,000. Each unit consists of one share of common stock and 0.40 of a warrant to purchase one share of common stock. The warrants will have an exercise price of $0.53 per share, will be exercisable from the date of issuance and will expire on the third anniversary of the issuance date. The offering is being made pursuant to an effective registration statement under the Securities Act of 1933, as amended.

(Logo: http://photos.prnewswire.com/prnh/20120419/NY91086LOGO )

iBio plans to use proceeds of the offering for working capital, including further development of iBio's product candidates and proprietary technology, business development and for other general corporate purposes. 

Roth Capital Partners is acting as sole manager for the offering. iBio expects to close the transaction, subject to customary conditions, on or about April 26, 2013.

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any offer or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The offering will be made only by means of a prospectus supplement and accompanying prospectus, copies of which may be obtained from:

Roth Capital Partners
By Email: rothecm@roth.com
By Fax: 949.720.7227
Or by mail:
888 San Clemente Drive
Newport Beach, CA 92660
ATTN: Equity Capital Markets


'/>"/>
SOURCE iBio, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. iBio, Inc. Submits Plan to Satisfy NYSE Amex Continued Listing Standards
2. iBio, Inc. Prices $10 Million Public Offering
3. iBio, Inc. and GE Healthcare form new global alliance
4. iBio, Inc. Receives Notice from NYSE MKT Staff that Company Currently is Below Certain Continued Listing Standards
5. iBio, Inc. Receives Anticipated Notice from NYSE MKT that Company is Below Certain Continued Listing Standards
6. iBio, Inc. Announces Proposed Public Offering
7. BioMed Realty, L.P. Prices $250 Million Offering Of 4.25% Senior Unsecured Notes Due 2022
8. Sequenom Prices Offering of $110 Million of its 5.00% Convertible Senior Notes Due 2017
9. Trending HealthEconomics.Com Pharma Pricing, Reimbursement, and Health Policy Stories Show Healthcare Payers Aren’t Taking Drug Prices Laying Down
10. BioMed Realty Trust Prices Public Offering Of 12,700,000 Shares Of Common Stock
11. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... manufacturer and supplier, announces the launch of their 2nd generation cell therapy POD® ... current miniPOD CT, but it also represents a new POD® design. , ...
(Date:7/29/2015)... Inc., an early stage biotech startup based on perinatal ... the Musculoskeletal Transplant Foundation of Edison NJ ... round of development of the proprietary AmnioCept™ product line ... AmnioChor,s technology allows cryopreservation of the amniotic membrane of ... those tissues. Amnion is a well-established source of multipotent ...
(Date:7/29/2015)... England , July 29, 2015  Indivior PLC ... (NDA) for naloxone nasal spray was accepted and received ... (FDA) for the treatment of opioid overdose. This naloxone ... naloxone specially formulated for optimal absorption into the nasal ... require minimal training so individuals may be better equipped ...
(Date:7/29/2015)... CITY , July 29, 2015 /PRNewswire/ - Aeterna ... today announced it has selected an optimized Erk ... milestone in the development of a new class ... MAPK pathway represents a prime target for therapeutic ... antitumor activities and survival benefits for B-Raf and ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... Calif., March 12 Avicena Group,Inc. (OTC Bulletin ... central nervous system therapeutics for neurodegenerative,diseases, announced today ... Administration,(FDA) and will proceed with a Phase III ... treatment of Huntington,s disease, pending final analysis of,completed ...
... Podcast you,will learn about how plant biotechnology can help ... conditions such as heat or cold and rain or ... badly. Because whenever these,conditions are not optimal, plants also ... that the reality today is that by now the,farmer,s ...
... and OSLO, March 12, Evotec AG (Frankfurt ... has chosen them as a partner to,identify ... Through the study of the physiology ... that cause fertilisation, Spermatech have,identified biological targets ...
Cached Biology Technology:Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 2Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 3Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial 4BASF Podcast - Better Harvest in Spite of Climate Stress 2BASF Podcast - Better Harvest in Spite of Climate Stress 3Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery 2Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery 3
(Date:7/31/2015)... , Chine, 31 juillet 2015 La ... www.icg-10.org ) sera organisée par le BGI du ... Shenzhen en Chine. La ... son inauguration en 2006, l,ICG est devenue l,une ... le domaine des « omiques » et c,est aussi la ...
(Date:7/31/2015)... , July 31, 2015 The 10 th ... be held by BGI from October 22-25, 2015, in ... The conference is celebrating its 10 th anniversary this ... of the world,s most influential annual meetings in the ,omics, ... enjoyable scientific gatherings. ICG-10 focuses on recent ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading ... for its second quarter ended June 30, 2015.  ... million, a decrease of 33% compared to $6.8 million in ... quarter of 2015 was $0.3 million, or $0.01 per diluted ... share, in the same period a year ago.  ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... ingredient in vinegar, acetic acid, can effectively kill ... an international team of researchers from Venezuela, France, ... the online open-access journal of the American Society ... as an inexpensive and non-toxic disinfectant against drug-resistant ...
... have found that a single genetic mutation causes resistance to ... With the continuing rise of resistance the research, published in ... say that this knowledge could help improve malaria control strategies. ... wide range of methods to narrow down how the resistance ...
... Scarborough shows that animal dispersal is influenced by a gene ... The study, which was carried out by UTSC Professor Mark ... first aimed at gaining a functional understanding of how genes ... common fruit flies ( Drosophila melanogaster ), the researchers observed ...
Cached Biology News:Vinegar kills tuberculosis and other mycobacteria 2Vinegar kills tuberculosis and other mycobacteria 3Researchers at LSTM crack the genetic secret of mosquito resistance to DDT and ITNs 2New study shows a genetic link between feeding behavior and animal dispersal 2
... Rabbit polyclonal to JMJD2D ( Abpromise ... Antigen: Synthetic peptide conjugated to KLH ... of Human JMJD2D.(Note: the amino acid sequence ... Entrez Gene ID: ...
Rabbit polyclonal to JAK1 (phospho Y1022 + Y1023) ( Abpromise for all tested applications). entrezGeneID: 3716 SwissProtID: P23458...
Cytofix/Cytoperm Plus Kit with GolgiPlug 250 Tests...
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Biology Products: